3-nitropropionic acid and vildagliptin

3-nitropropionic acid has been researched along with vildagliptin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Fathy, N; Kamel, AS; Kortam, MA; Mohamed, AF; Rabie, MA; Sayed, NH	1

Other Studies

1 other study(ies) available for 3-nitropropionic acid and vildagliptin

Article	Year
Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2020, Volume: 17, Issue:1 Topics: Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Corpus Striatum; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Glucagon-Like Peptide-1 Receptor; Huntington Disease; Male; Maze Learning; Nitro Compounds; Phosphatidylinositol 3-Kinase; Propionates; Proto-Oncogene Proteins c-akt; Rats, Wistar; Rotarod Performance Test; Signal Transduction; Vildagliptin	2020

Article

Year

Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2020, Volume: 17, Issue:1

Topics: Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Corpus Striatum; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Glucagon-Like Peptide-1 Receptor; Huntington Disease; Male; Maze Learning; Nitro Compounds; Phosphatidylinositol 3-Kinase; Propionates; Proto-Oncogene Proteins c-akt; Rats, Wistar; Rotarod Performance Test; Signal Transduction; Vildagliptin

2020